Selinexor
MCC-18157
Phase 2 small_molecule completed
Quick answer
Selinexor for Leukemia is a Phase 2 program (small_molecule) at Karyopharm Therapeutics with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Karyopharm Therapeutics
- Indication
- Leukemia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed